Access Toxo IgM II 34470Recalls & reported problems
Beckman Coulter, Inc. · The Access Toxo IgM II assay is a paramagnetic-particle chemiluminescent immunoassay for the qualitative detection of Toxoplasma gondii-specific IgM antibody in adult human serum and plasma using the Access Immunoassay Systems. · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 15099590624804), received between Oct 1, 2018 and Oct 1, 2018 — classified as 1 injury.
The most frequently reported specific device problem is “False Positive Result” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- False Positive Result1
Patient problems
- No Code Available1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryOct 1, 2018False Positive Result; False Positive Result
THE CUSTOMER REPORTED OBTAINING A REPRODUCIBLE REACTIVE TOXOPLASMOSIS GONDII IGM (ACCESS TOXO IGM) RESULT FOR ONE PREGNANT FEMALE (1) PATIENT ON THE LABORATORY'S ACCESS 2 IMMUNOASSAY SYSTEM (SERIAL NUMBER (B)(4)). THE CUSTOMER REANALYZED THE PATIENT'S SAMPLE ON THE SAME ACCESS 2 IMMUNOASSAY SYSTEM TWO (2) ADDITIONAL TIMES USING NEW SAMPLES EACH TIME AND OBTAINED REACTIVE RESULTS. THE PATIENT'S TOXOPLASMOSIS GONDII IGG (ACCESS TOXO IGG) RESULTS WERE ALL NON-REACTIVE. THEREFORE, THE ACCESS TOXO IGM RESULTS WERE IN QUESTION BY THE PHYSICIAN. THE INITIAL, REACTIVE ACCESS TOXO IGM RESULT WAS REPORTED OUTSIDE THE LABORATORY. THE PATIENT WAS THEN ADMINISTERED AN ANTIBIOTIC DUE TO THE REACTIVE ACCESS TOXO IGM RESULT OBTAINED. THE EXACT ANTIBIOTIC WAS NOT NAMED BY CUSTOMER. QUALITY CONTROL (QC) AND CALIBRATIONS WERE PERFORMING WITHIN ASSAY AND INSTRUMENT SPECIFICATIONS AT THE TIME OF THE EVENT. NO ERRORS WERE POSTED TO THE INSTRUMENT'S EVENT LOG IN CONJUNCTION WITH THIS EVENT. THE CUSTOMER DID NOT PROVIDE SAMPLE COLLECTION AND PROCESSING INFORMATION SUCH AS TUBE TYPE, CENTRIFUGATION TIME AND CENTRIFUGATION SPEED.
Patient problems: No Code Available
MAUDE report 7922857 ↗
Other Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii devices
- Atellica IM Toxo G 10995699Siemens Healthcare Diagnostics Inc. · ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII92 reports
- ADVIA Centaur® Toxo G 10310321Siemens Healthcare Diagnostics Inc. · ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII68 reports
- VIDAS® TOXOIgG AVIDITY 30222-01Biomerieux SA · Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii1 recall0 reports
- BioPlex 2200 12000670Bio-Rad Laboratories, Inc. · ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII1 recall0 reports
- IMMULITE® 2000 Systems TXP Toxoplasma Quantitatve IgG 10381323Siemens Healthcare Diagnostics Products Ltd · ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII49 reports
- Elecsys Toxo IgM 07028024190Roche Diagnostics GmbH · ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII42 reports
- Elecsys Toxo IgM 04618858190Roche Diagnostics GmbH · ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII29 reports
- Elecsys Toxo IgG 07028008190Roche Diagnostics GmbH · ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII22 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page